Mallinckrodt’s stannsoporfin turned away by FDA
23 Aug 2018 //
PHARMA TIMES
After AdComm rejection, Mallinckrodt’s stannsoporfin gets stiff-armed at FDA
22 Aug 2018 //
FIERCE BIOTECH
Mallinckrodt Reports on FDA Joint Advisory Committee Meeting for Stannsoporfin
03 May 2018 //
PR NEWSWIRE
Mallinckrodt Receives FDA Acceptance of Stannsoporfin NDA Filing
24 Feb 2018 //
PR NEWSWIRE
Mallinckrodt To Acquire InfaCare Pharmaceutical Corporation And Stannsoporfin
05 Aug 2017 //
PR NEWSWIRE
InfaCare Announces the Successful Completion of its Phase IIB program
24 Mar 2016 //
PR NEWSWIRE